metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Validation of a diagnostic questionnaire for migraine adapted for a computer ass...
Journal Information
Vol. 25. Issue 3.
Pages 163-167 (April 2010)
Share
Share
Download PDF
More article options
Vol. 25. Issue 3.
Pages 163-167 (April 2010)
Full text access
Validation of a diagnostic questionnaire for migraine adapted for a computer assisted telephone interviewing
Validación de un cuestionario diagnóstico para migraña adaptado para encuesta telefónica asistida por ordenador
Visits
2767
J. Porta-Etessama, A. López-Gilb, J. Matías-Guiua,
Corresponding author
inc.hcsc@salud.madrid.org

Author for correspondence.
, C. Fernándeza, on behalf of Comité Científico del Programa PALM
a Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain
b Departamento Médico, Merck Sharp & Dohme de España, Madrid, Spain
This item has received
Article information
Abstract
Introduction

The use of questionnaires is a tool for obtaining information on cases and the variables to analyse in migraine study populations.

Methods

We have validated the questionnaire within the PALM study, based on IHS-II criteria and administered by telephone using computer assisted sampling (CATI). The questionnaire was validated using 50 randomly selected subjects, who had been assessed blind by a neurologist expert in migraine.

Results

Of the 24 patients diagnosed with strict migraine with the CATI interview, only in 2 (8%) of them did the neurologist determine that they did not suffer from migraine. Furthermore, of the patients in whom the diagnostic questionnaire concluded that they did not suffer from migraine, the specialist did not establish that diagnosis in any of them either. The analysis showed a sensitivity of 81.5% (95% CI, 66.8%–96.1%) and a specificity of 91.3% (95% CI, 79.8%–100%). The positive predictive value was 91.7% and the negative was 80.8%.

Conclusions

The PALM questionnaire administered by telephone with computer support is a valid tool for use in determining the prevalence of migraine in study populations.

Keywords:
Migraine
Diagnosis
Telephone survey
Sensitivity
Specificity
Resumen
Introducción

La utilización de cuestionarios es la fórmula de obtención de la información sobre los casos y las variables que analizar en los estudios poblacionales de migraña.

Métodos

Hemos realizado la validación del cuestionario dentro del estudio PALM, basado en los criterios de IHS-II y administrado telefónicamente según un muestreo asistido por ordenador (CATI). Se ha validado mediante el estudio de 50 sujetos elegidos aleatoriamente y analizados de forma ciega por un neurólogo experto en migraña.

Resultados

De los 24 pacientes diagnosticados de migraña estricta con la entrevista CATI, en tan sólo 2 (8%) de ellos el neurólogo determinó que no tenían migraña. Sin embargo, de entre los pacientes en que el cuestionario diagnóstico no concluyó que padecieran migraña no hubo ninguno en que el especialista estableciera dicho diagnóstico. El análisis reveló una sensibilidad del 81,5% (intervalo de confianza [IC] del 95%, 66,8%–96,1%) y una especificidad del 91,3% (IC del 95%, 79,8%–100%). El valor predictivo positivo fue del 91,7% y el negativo del 80,8%.

Conclusiones

El cuestionario PALM, administrado telefónicamente con apoyo de ordenador, es un instrumento válido para su uso en la determinación de la prevalencia de migraña en estudios poblacionales.

Palabras clave:
Migraña
Diagnóstico
Encuesta telefónica
Sensibilidad
Especificidad
Full text is only aviable in PDF
References
[1.]
J.E. Magnusson, W.J. Becker.
Migraine frequency and intensity: relationship with disability and psychological factors.
Headache, 43 (2003), pp. 1049-1059
[2.]
J. Berg, L.J. Stovner.
Cost of migraine and other headaches in Europe.
Eur J Neurol, 12 (2005), pp. 59-62
[3.]
L.J. Stovner, J.A. Zwart, K. Hagen, G.M. Terwindt, J. Pascual.
Epidemiology of headache in Europe.
Eur J Neurol, 13 (2006), pp. 333-345
[4.]
J. Olesen.
The international classification of headache disorders.
[5.]
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160.
[6.]
T.J. Steiner, A.I. Scher, W.F. Stewart, K. Kolodner, J. Liberman, R.B. Lipton.
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity.
Cephalalgia, 23 (2003), pp. 519-527
[7.]
D.A. Marcus, C. Kapelewski, R.G. Jacob, T.E. Rudy, J.M. Furman.
Validation of a brief nurse-administered migraine assessment tool.
[8.]
R.B. Lipton, W.C. Stewart, S. Solomon.
Questionnaire versus clinical interview in the diagnosis of headache.
Headache, 32 (1992), pp. 55-56
[9.]
B.K. Rasmussen, R. Jensen, J. Olesen.
Questionnaire versus clinical interview in the diagnosis of headache.
Headache, 31 (1991), pp. 290-295
[10.]
R. Sánchez-Pérez, M. Asensio, A. Melchor, I. Montiel, R. Falip, J.M. Moltó, et al.
Clinical features of migraine according to the questionnaire“Alcoi-92” in the Comtat area.
Rev Neurol, 28 (1999), pp. 459-463
[11.]
M. Gervil, V. Ulrich, J. Olesen, M.B. Russell.
Screening for migraine in the general population: validation of a simple questionnaire.
Cephalalgia, 18 (1998), pp. 342-348
[12.]
K. Hagen, J.-A. Zwart, L. Vatten, L.J. Stovner, G. Bovim.
Head-HUNT: Validity and reliability of a headache questionnaire in a large population-based study in Norway.
Cephalalgia, 20 (2000), pp. 244-251
[13.]
T. Tom, M. Brody, A. Valabhji, L. Turner, C. Molgaard, J. Rothrock.
Validation of a new instrument for determining migraine prevalence: The UCSD Migraine Questionnaire.
Neurology, 44 (1994), pp. 925-928
[14.]
F. Sakai, H. Igarashi.
Prevalence of migraine in Japan: A nationwide survey.
Cephalalgia, 17 (1997), pp. 15-22
[15.]
P. Michel, P. Henry, L. Letenneur, M. Jogeix, A. Corson, J.F. Dartigues.
Diagnostic screening for assessment of the IHS criteria for migraine by general practitioners.
Cephalalgia, 13 (1993), pp. 54-59
[16.]
I.J. Benseñor, P.A. Lotufo, A.C. Pereira, A.C. Tannuri, F.K. Issa, D. Akashi, et al.
Validation of a questionnaire for the diagnosis of headache in an outpatient clinic at a university hospital.
Arq Neuropsiquiatr, 55 (1997), pp. 364-369
[17.]
L. Galiano, I.H. Montiel, A. Melchor, R. Falip, M. Asensio, J. Matias-Guiu.
Validation of a Spanish Questionnaire to perform a population-based study of the prevalence of headache.
Headache Classification and Epidemiology, pp. 213-215
[18.]
J.M. Pereira-Monteiro, R.J.A.R. Maio, J.M. Calheiros.
Headache diagnosis. Comparison of questionnaire with clinical interview.
Headache Classification and Epidemiology, pp. 217-220
[19.]
M.J.A. Láinez, J. Vioque, I. Hernández-Aguado, F. Titus.
Prevalence of migraine in Spain. An assessment of the questionnaire”s validity by the clinical interview.
Headache Classification and Epidemiology, pp. 221-225
[20.]
M.J.A. Láinez, M. Domínguez, J. Rejas, et al.
Development and validation of the Migraine Screen Questionnaire (MS-Q).
Headache, 45 (2005), pp. 1328-1338
[21.]
I. Montiel, R. Muñiz, M. Asensio, M.J. González, R. Martín, C. Díaz-Marín, et al.
Development of a new questionnaire in Spanish for diagnosis of migraine.
Rev Neurol, 25 (1997), pp. 2056-2057
[22.]
I. Montiel, R. Muñiz, M. Asensio, C. Ruiz, C. Díaz-Marín, J. Matías-Guiu.
Validity and reliability of the migraine self-questionnaire Alcoi-1995.
Rev Neurol, 25 (1997), pp. 1173-1177
[23.]
M.S. Yoon, M. Obermann, G. Fritsche, M. Slomke, P. Dommes, C. Schilf, et al.
Population-based validation of a German-language self-administered headache questionnaire.
Cephalalgia, 28 (2008), pp. 605-608
[24.]
G. Fritsche, M. Hueppe, M. Kukava, A. Dzagnidze, M. Schuerks, M.S. Yoon, et al.
Validation of a questionnaire in the diagnosis of headache.
[25.]
M. Kukava, A. Dzagnidze, M. Janelidze, E. Mirvelashvili, M. Djibuti, G. Fritsche, et al.
Validation of a Georgian language headache questionnaire in a population-based sample.
Headache Pain, 8 (2007), pp. 321-324
[26.]
M. Schürks, J.E. Buring, T. Kurth.
Agreement of self-reported migraine with ICHD-II criteria in the Women”s Health Study.
Cephalalgia, 29 (2009), pp. 1086-1090
[27.]
M. Rueda-Sánchez, L.A. Díaz-Martínez.
Validation of a migraine screening questionnaire in a Colombian university population.
Cephalalgia, 24 (2004), pp. 894-899
[28.]
M. Kallela, M. Wessman, M. Färkkilä.
Validation of a migrainespecific questionnaire for use in family studies.
Eur J Neurol, 8 (2001), pp. 61-66
[29.]
M.F. Facheris, F.D. Vogl, S. Hollmann, G. Sixt, C. Pattaro, R. Schönhuber, et al.
Adapted Finnish Migraine-Specific Questionnaire for family studies (FMSQ(FS)): a validation study in two languages.
Eur J Neurol, 15 (2008), pp. 1071-1074
[30.]
L. Valentinis, F. Valent, M. Mucchiut, F. Barbone, P. Bergonzi, G. Zan-chin.
Migraine in adolescents: validation of a screening questionnaire.
[31.]
R.B. Lipton, D. Dodick, R. Sadovsky, K. Kolodner, J. Endicott, J. Hettiarachchi, et al.
A self-administered screener for migraine in primary care: The ID Migraine validation study.
Neurology, 61 (2003), pp. 375-382
[32.]
Gil-Gouveia R, Martins I. Validation of the Portuguese Version of ID-Migraine. Headache 2009: doi: 10.1111/j.1526-4610.2009. 01449.x.
[33.]
F. Brighina, G. Salemi, B. Fierro, A. Gasparro, G. Balletta, A. Aloisio, et al.
A validation study of an Italian version of the ID Migraine: preliminary results.
J Headache Pain, 6 (2005), pp. 216-219
[34.]
F. Brighina, G. Salemi, B. Fierro, A. Gasparro, A. Balletta, A. Aloisio, et al.
A validation study of an Italian version of the ID Migraine.
[35.]
N. Karli, M. Ertas, B. Baykan, et al.
The validation of ID Migraine screener in neurology outpatient clinics in Turkey.
J Headache Pain, 8 (2007), pp. 217-223
[36.]
A. Siva, M. Zarifoglu, M. Ertas, S. Saip, H.N. Karli, B. Baykan, et al.
Validity of the ID-Migraine screener in the workplace.
[37.]
M. Zarifoglu, N. Karli, O. Taskapilioglu.
Can ID Migraine be used as a screening test for adolescent migraine?.
[38.]
R.B. Lipton, A.I. Scher, K. Kolodner, J. Liberman, T.J. Steiner, W.F. Stewart.
Migraine in the United States: epidemiology and patterns of health care use.
Neurology, 58 (2002), pp. 885-894
[39.]
S.J. Wang, J.L. Fuh, S.R. Lu.
Chronic daily headache in adolescents: an 8-year follow-up study.
Neurology, 73 (2009), pp. 416-422
[40.]
C. Kirk, G. Nagiub, I. Abu-Arafeh.
Chronic post-traumatic headache after head injury in children and adolescents.
Dev Med Child Neurol, 50 (2008), pp. 422-425
[41.]
M. Kirchmann, E. Seven, A. Björnsson, G. Björnssdóttir, J.R. Gulcher, K. Stefánsson, et al.
Validation of the deCODE Migraine Questionnaire (DMQ3) for use in genetic studies.
Eur J Neurol, 13 (2006), pp. 1239-1244
[42.]
M.B. Russell, B.K. Rasmussen, P. Thorvaldsen, J. Olesen.
Prevalence and sex-ratio of the subtypes of migraine.
Int J Epidemiol, 24 (1995), pp. 612-618
[43.]
T.W. Wong, K.S. Wong, T.S. Yu, R. Kay.
Prevalence of migraine and other headaches in Hong Kong.
Neuroepidemiology, 14 (1995), pp. 82-91
[44.]
C. Dahlöf, M. Linde.
One-year prevalence of migraine in Sweden: a population-based study in adults.
Cephalalgia, 21 (2001), pp. 664-671
[45.]
J.E. Ware Jr., M. Kosinski, J.B. Bjorner, M.S. Bayliss, A. Batenhorst, C.G. Dahlöf, et al.
Applications of computerized adaptive testing (CAT) to the assessment of headache impact.
Qual Life Res, 12 (2003), pp. 935-952
Copyright © 2010. Sociedad Española de Neurología
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos